Rhein Laser Technologies has introduced the new UroFiber 150Q SuperPulsed thulium fiber laser (TFL) system to treat stone lithotripsy.

Claimed to be the world’s first 150W SuperPulsed TFL system, UroFiber 150Q will also help treat benign prostatic hyperplasia (BPH) enucleation.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

To attain the high power 1940nm continues mode (CW) and SuperPulsed mode (QCW) laser, UroFiber 150Q uses all-fibre technology with customised high-brightness narrow spectrum fibre-coupling 792nm diode laser pumping thulium fibre.

The system’s peak power can reach 600W, with up to 150W average output power in QCW, while the maximum laser repetition rate can attain 5000Hz with a minimum single pulse energy of 0.025J.

UroFiber 150Q’s maximum frequency is 25Hz, with single pulse laser energy of 6J, and it can reach the highest power up to 150W in CW.

According to the company, the system is in line with the industry standard of continuous operation with less than 60dB noise level.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Furthermore, according to experts TFL enucleation of BPH is anticipated to replace the traditional transurethral enucleation of the prostate, stated Rhein Laser.

Rhein Laser CEO Dr Lin Yang said: “We’re very thrilled to launch this system, as we believe it will definitely make a new breakthrough in laser technology that will inspire urologists to achieve better outcomes with all-in-one system.

“Now we’re expecting to see more cases that will show a growing number of patients singing high praise of the great efficacy of UroFiber 150Q after use. We spare no efforts to make people healthier, safer and more meaningful.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact